Nijhuis, Amanda A. G.
Dieng, Mbathio
Khanna, Nikita
Lord, Sally J.
Dalton, Jo
Menzies, Alexander M.
Turner, Robin M.
Allen, Jay
Saw, Robyn P. M.
Nieweg, Omgo E.
Thompson, John F.
Morton, Rachael L.
Article History
Received: 18 October 2018
First Online: 25 March 2019
Disclosure
: Alexander M. Menzies has been on an advisory board for Bristol Meyers Squibb, Merck Sharp Dome, Novartis, and Pierre-Fabre, and has received speaking honoraria from Roche. Robyn P.M. Saw has been on an advisory board for Bristol Meyers Squibb, Merck Sharp Dome, Novartis, and Amgen, and has received a speaking honorarium from Bristol Meyers Squibb. John F. Thompson has been on an advisory board for and received honoraria and travel support from Bristol Meyers Squibb, Merck Sharp Dome, Provectus Inc., and GlaxoSmithKline. Amanda A.G. Nijhuis, Mbathio Dieng, Nikita Khanna, Sally J. Lord, Jo Dalton, Robin M. Turner, Jay Allen, Omgo E. Nieweg, and Rachael L. Morton have no conflicts of interest to declare.